The House plans to take up a tri-committee package of pharmacy benefit manager reforms, provider price transparency, hospital drug administration site-neutral pay and extenders next week under suspension of the rules, according to the Congressional Budget Office, but that office does not yet have an estimate on the cost of the package. Under the suspension of the rules, floor debate is limited prior to a House vote and all floor amendments are prohibited while points of order against the bill...